David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPX
551
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $28.8M | 0.04% |
1,161,746
+85,221
| +8% | +$2.24M |
|
552
Appian
APPN
$2.81B
| $28.7M | 0.04% |
833,373
+588,810
| +241% | +$19.9M |
|
|
BPYU
553
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $28.6M | 0.04% |
1,397,866
-2,372,375
| -63% | -$45M |
|
554
Ashland
ASH
$3.38B
| $28.6M | 0.04% |
365,982
-216,640
| -37% | -$16.7M |
|
555
Resideo Technologies
REZI
$2.93B
| $28.5M | 0.04% |
1,478,235
-1,323,782
| -47% | -$29.3M |
|
556
Planet Fitness
PLNT
$4.07B
| $28.5M | 0.04% |
414,061
+385,687
| +1,359% | +$23.4M |
|
557
PUT
Boeing
BA
$166B
| $28.5M | 0.04% |
74,600
-148,800
| -67% | -$57.3M |
|
558
CALL
Comcast
CMCSA
$95.9B
| $28.4M | 0.04% |
710,800
+456,000
| +179% | +$17.2M |
|
|
X
559
CALL
DELISTED
US Steel
X
| $28.3M | 0.04% |
1,453,600
+350,900
| +32% | +$7.46M |
|
560
Eastman Chemical
EMN
$8.31B
| $28.3M | 0.04% |
372,615
+88,247
| +31% | +$7.01M |
|
|
WAGE
561
DELISTED
WageWorks, Inc.
WAGE
| $28.2M | 0.04% |
746,735
+288,590
| +63% | +$9.42M |
|
562
McKesson
MCK
$102B
| $28M | 0.04% |
239,242
-110,320
| -32% | -$13.6M |
|
563
3D Systems Corp
DDD
$518M
| $28M | 0.04% |
2,597,952
-482,150
| -16% | -$5.73M |
|
564
CALL
Northrop Grumman
NOC
$78B
| $27.9M | 0.04% |
103,600
-29,100
| -22% | -$7.94M |
|
|
XLNX
565
DELISTED
Xilinx Inc
XLNX
| $27.9M | 0.04% |
219,827
-391,075
| -64% | -$43.9M |
|
566
PUT
Constellation Brands
STZ
$23.5B
| $27.8M | 0.04% |
158,600
+118,800
| +298% | +$20M |
|
567
Huntsman Corp
HUN
$1.68B
| $27.7M | 0.04% |
1,231,304
-2,466
| -0.2% | -$55.5K |
|
568
Shutterstock
SSTK
$198M
| $27.5M | 0.04% |
589,445
+49,063
| +9% | +$2.07M |
|
569
Sanmina
SANM
$9.94B
| $27.5M | 0.04% |
952,041
-16,874
| -2% | -$497K |
|
570
Okta
OKTA
$22.8B
| $27.4M | 0.04% |
331,547
-327,094
| -50% | -$25.9M |
|
571
Penumbra
PEN
$12.8B
| $27.2M | 0.04% |
184,907
-93,068
| -33% | -$13.3M |
|
572
PUT
Weibo
WB
$1.72B
| $27.2M | 0.04% |
438,200
-33,200
| -7% | -$2.06M |
|
573
Kulicke & Soffa
KLIC
$4.37B
| $27.1M | 0.04% |
1,225,083
-232,078
| -16% | -$5.13M |
|
|
ARRS
574
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $27M | 0.03% |
855,182
-313,232
| -27% | -$9.82M |
|
|
575
CALL
Pfizer
PFE
$159B
| $27M | 0.03% |
669,185
+39,842
| +6% | +$1.6M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.